We are live on ! Find out more
BA

BlackRock Advisors Portfolio holdings

AUM $98.8B
1-Year Est. Return 15.8%
This Fund
S&P 500
This Quarter Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
Cap. Flow
+$5.74B
Cap. Flow %
6.15%
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$423M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$367M
3
XOM icon
ExxonMobil
XOM
+$337M
4
JNJ icon
Johnson & Johnson
JNJ
+$257M
5
BIIB icon
Biogen
BIIB
+$250M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$195M
2
ABBV icon
AbbVie
ABBV
+$188M
3
JPM icon
JPMorgan Chase
JPM
+$183M
4
BMY icon
Bristol-Myers Squibb
BMY
+$176M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$174M

Sector Composition

Rank Sector Weight
1 Healthcare 18.49%
2 Financials 16.75%
3 Technology 9.99%
4 Industrials 8.32%
5 Energy 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVR icon
3601
Chicago Rivet & Machine Co
CVR
$9.56M
$12K ﹤0.01%
494
– –
INVE icon
3602
Identive
INVE
$64.6M
$12K ﹤0.01%
3,365
+1,437
+75% +$6.36K
ISSC icon
3603
Innovative Solutions & Support
ISSC
$342M
$12K ﹤0.01%
4,600
– –
MTEX icon
3604
Mannatech
MTEX
$8.68M
$12K ﹤0.01%
644
– –
RKDA icon
3605
Arcadia Biosciences
RKDA
$1.4M
$12K ﹤0.01%
5
– –
TRI icon
3606
Thomson Reuters
TRI
$39.4B
$12K ﹤0.01%
+252
New +$11.5K
STAB
3607
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$12K ﹤0.01%
2,800
– –
DTRM
3608
DELISTED
Determine, Inc. Common Stock
DTRM
$12K ﹤0.01%
2,985
– –
KTEC
3609
DELISTED
Key Technology Inc
KTEC
$12K ﹤0.01%
998
– –
PFBX
3610
DELISTED
Peoples Financial Corp/MS
PFBX
$12K ﹤0.01%
1,245
– –
CFNB
3611
DELISTED
California First National Banc
CFNB
$12K ﹤0.01%
882
– –
WINT
3612
DELISTED
Windtree Therapeutics Inc
WINT
$12K ﹤0.01%
2,806
+1,210
+76% +$8.01K
FWM
3613
DELISTED
FAIRWAY GROUP HLDGS CORP CL A COM STK (DE)
FWM
$12K ﹤0.01%
11,330
– –
SFXE
3614
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
$12K ﹤0.01%
23,327
– –
EPAX
3615
DELISTED
Ambassadors Group Inc
EPAX
$12K ﹤0.01%
4,485
– –
WRES
3616
DELISTED
WARREN RESOURCES INC
WRES
$12K ﹤0.01%
25,482
+11,940
+88% +$5.47K
AIM
3617
AIM ImmunoTech
AIM
$6.9M
$12K ﹤0.01%
1
– –
ARL icon
3618
American Realty Investors
ARL
$239M
$11K ﹤0.01%
1,631
– –
CIX icon
3619
Comp X International
CIX
$329M
$11K ﹤0.01%
1,034
– –
HEPA
3620
DELISTED
Hepion Pharmaceuticals
HEPA
– –
0
– –
LTRX icon
3621
Lantronix
LTRX
$236M
$11K ﹤0.01%
9,095
– –
MBOT icon
3622
Microbot Medical
MBOT
$115M
$11K ﹤0.01%
16
– –
OMEX icon
3623
Odyssey Marine Exploration
OMEX
$40.4M
$11K ﹤0.01%
2,445
– –
SMSI icon
3624
Smith Micro Software
SMSI
$14M
$11K ﹤0.01%
77
– –
AIOT
3625
PowerFleet Inc
AIOT
$500M
$11K ﹤0.01%
3,541
– –
143 144
145
146 147

Similar funds

BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
BJ
BlackRock Japan Tokyo, Japan $30.3B AUM 13.85% 1-Year Est. Return
IC
Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
MFS
MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return
CIM
Calvert Investment Management Bethesda, Maryland $2.67B AUM 16.23% 1-Year Est. Return
KAM
Keeley Asset Management Chicago, Illinois $2.35B AUM 26.92% 1-Year Est. Return
PFM
PacWest Financial Management Phoenix, Arizona $1.69B AUM 8.84% 1-Year Est. Return

BlackRock Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.

  • BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
  • BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
  • BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
  • BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
  • BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
  • BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
  • BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.

Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.